Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

Techniques and graft materials for repairing peripheral nerve defects
Xiaodi Zou, Yanzhao Dong, Ahmad Alhaskawi, et al.
Frontiers in Neurology (2024) Vol. 14
Open Access | Times Cited: 9
Engineered hydrogel platform for diabetic wound healing
Jie Cui, Jianbin Shi, Yanjun Liu, et al.
Chemical Engineering Journal (2025), pp. 160379-160379
Closed Access | Times Cited: 1
Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future
Leonard A. Levin, Christopher Patrick, Nozhat Choudry, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 25
Strategic approaches for antiglaucoma drug discovery—Successes and some failures
Najam A. Sharif
Elsevier eBooks (2025), pp. 359-383
Closed Access
Electroceuticals and optogenetics for neuroprotection, vision preservation and restoration
Najam A. Sharif, Samarendra Mohanty
Elsevier eBooks (2025), pp. 163-178
Closed Access
Could nerve transplantation be the future of this field: a bibliometric analysis about lumbosacral plexus injury
Sheng Wang, Demeng Xia, Danyan Song, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 3
Elevated Intraocular Pressure and Glaucomatous Optic Neuropathy: Genes to Disease Mechanisms, Therapeutic Drugs, and Gene Therapies
Najam A. Sharif
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 870-870
Open Access | Times Cited: 6
Recently Approved Drugs for Lowering and Controlling Intraocular Pressure to Reduce Vision Loss in Ocular Hypertensive and Glaucoma Patients
Najam A. Sharif
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 791-791
Open Access | Times Cited: 5
Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma
Najam A. Sharif
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101218-101218
Closed Access | Times Cited: 2
Eye Disease Genetics and Therapeutics
Najam A. Sharif, Nozhat Choudry, Saima D. Chaudhry, et al.
Essentials in ophthalmology/Essentials ophthalmology (2024), pp. 225-255
Closed Access
Efficacy of Intravitreal Multi-Characteristic Opsin (MCO-010) Optogenetic Gene Therapy in a Mouse Model of Leber Congenital Amaurosis
Adnan Dibas, Subrata Batabyal, Sang Hoon Kim, et al.
Journal of Ocular Pharmacology and Therapeutics (2024)
Closed Access
Footwear for Diabetics – Structural and Material Elements for the Prevention and Alleviation of Foot Lessions
Iwona Masłowska‐Lipowicz, Magda Adamczyk, Robert Gajewski, et al.
Fibres and Textiles in Eastern Europe (2024) Vol. 32, Iss. 5, pp. 1-14
Open Access
Role of Neural Circuits in Cognitive Impairment
Li Zhang, Guodong Liu, Yaonan Peng, et al.
Neurochemical Research (2024) Vol. 50, Iss. 1
Closed Access
Page 1

Scroll to top